Background: Underweight eating disorders (EDs) are notoriously difficult to treat, although a growing evidence base suggests that outpatient cognitive behaviour therapy for EDs (CBT-ED) can be effective for a large proportion of individuals.
Introduction
In the field of eating disorders (EDs), a number of evidence-based treatments have 'earned their stripes', with those based around cognitive behavioural principles often foremost in the treatment of these illnesses in adults (Steiger, 2017) . Cognitive behaviour therapy for EDs, known as CBT-ED (e.g., NICE, 2017) , has been widely investigated and its efficacy supported in randomised controlled trials and metaanalyses (e.g., see Linardon, Wade, De La Piedad Garcia, and Brennan, 2017) .
However, there is often assumed to be a gap between what is provided in research settings (where the majority of evidence for efficacy is collected) and in 'real world' settings (e.g., see Shafran et al., 2009; Wallace & von Ranson, 2012) . In order to address this, a number of recent studies have looked at the effectiveness of evidence-based CBT-ED for adults in outpatient clinical settings (e.g., Byrne, Fursland, Allen, and Watson, 2011; Knott, Woodward, Hoefkens, and Limbert, 2015; Rose and Waller, 2017; Serpell, Stobie, Fairburn, and van Schaick, 2013; Signorini, Sheffield, Rhodes, Fleming, and Ward, 2017; Turner, Marshall, Stopa, and Waller, 2015; Waller et al., 2014) . Such studies are important as they can support findings of well-conducted research trials (e.g., Byrne et al., 2017; Fairburn et al., 2009; Fairburn et al., 2013; Fairburn et al. 2015) and demonstrate treatment efficacy in settings where "there are few exclusion criteria and where adherence to evidencebased protocols is less intensively monitored" (Turner et al., 2015, p. 73) .
Of those studies conducted on individual CBT-ED, significant improvements have been reported. Around 50 -60% of patients complete treatment (Byrne et al., 2011; Knott et al., 2015; Turner et al., 2015) , with medium to large effect sizes observed on measures of eating pathology and general psychiatric symptoms. Symptom change, commonly assessed with the self-report EDE-Q (Eating Disorder Examination -Questionnaire; Fairburn and Beglin, 2008) , suggests that CBT-ED improves ED attitudes as well as behaviours such as binge eating and purging. Similarly, there is growing evidence that effects extend beyond symptom change and are associated with improvements in quality of life (Linardon and Brennan, 2017) , although many studies have not included measures of quality of life or psychosocial impairment (e.g., Rose and Waller, 2017) .
Studies relating to the treatment of anorexia nervosa (AN) are important given the high treatment costs and the physical and psychological comorbidities associated with this illness (Agras et al., 2004; Byrne et al., 2017; Halmi et al., 2005) . Furthermore, atypical AN (i.e., seen in individuals with clinically significant symptoms for whom one or more of the key symptoms of AN, but not necessarily low weight, is absent; Fairburn and Walsh, 2002) has been understudied (e.g., Santonastaso et al., 2009 ) and assessing outcome can be complex (Hughes et al., 2017) . An additional component of interventions for low weight EDs, such as AN, is the focus on weight restoration as a key goal of treatment, which often necessitates longer duration of treatment (e.g., Byrne et al., 2017) . Evaluation of CBT-ED for AN-type disorders in 'real world' settings has been limited, with such individuals often only included as part of a larger sample (e.g., Byrne et al., 2011; Rose and Waller, 2017; Signorini et al., 2017; Turner et al., 2015) . These shortcomings are also compounded by the fact that sample sizes in treatment studies of AN are generally small, averaging around 20 (Fairburn et al., 2013; see also Linardon et al., 2017) . However, two recent trials (Byrne et al., 2017; Fairburn et al., 2013) have reported outcomes for underweight individuals receiving CBT-ED, and generally support findings from non-underweight studies. Thus, although CBT-ED can be applied as a 'transdiagnostic' treatment (Fairburn, 2008) , it is important to generalise efficacy of such approaches to lowweight patients in 'real world' settings.
The current study aims to describe engagement and outcomes in a sample of consecutively treated adults with underweight EDs. Specifically, it will address four key questions (Fairburn et al., 2013) : 1. What proportion of patients with underweight EDs complete CBT-ED in 'real world' clinical settings? 2. What is the outcome of patients who complete treatment? 3. Does psychosocial impairment also change following treatment? 4. Do any baseline variables predict treatment completion?
Finally, given recent interest in duration of psychological treatments for EDs (e.g., Bell, Waller, Shafran, and Delgadillo, 2017; Waller et al., 2018) , we were also interested in the duration of treatment, and whether the number of treatment sessions was associated with outcome.
Method

Participants
The study was conducted within a specialist outpatient Eating Disorders Service within the UK National Health Service (NHS). The service provides assessment and treatment to adults (aged over 17 ½ years) ordinarily resident within a local catchment area (total population of around 1.3 million). Patients must first be referred to the service by another healthcare professional, such as a general practitioner, and are then offered treatment at no charge.
Participants were included in the study if they: a) received an ICD-10 diagnosis of AN or Atypical AN (WHO, 2016) following assessment with the service; b) had a BMI <18.5 at start of treatment; c) had a complete set of self-report measures at start of treatment; d) subsequently received at least one session of outpatient CBT-ED; e) were not receiving additional psychological therapy, inpatient, or daypatient treatment when starting CBT-ED; and f) started treatment between July 2013 and March 2017. Of note, individuals with a diagnosis of Atypical AN were excluded from the study if their BMI was greater than 18.5kg/m 2 . Approval for conduct of the study was obtained from the local NHS Trust, who noted that further ethical review was not required as this was a retrospective review of routinely-collected, de-identified data.
Initial assessment was conducted via clinical interview, lasting approximately 90 minutes. Although similar areas are covered by clinicians, this did not adhere to a standardised interview (e.g., the EDE; Fairburn, 2008). Where ICD-10 (WHO, 2016) diagnosis was unclear, this was agreed upon following team discussion.
The final sample included 62 females and one male with underweight EDs (see Figure 1 ). All were asked to complete questionnaires at both pre-and posttreatment. Further demographic information (at start of treatment) is shown in Table   1 .
INSERT TABLE 1
Measures nearest 5mm and 0.1kg respectively). To assess outcome, the Global score of the EDE-Q (Fairburn and Beglin, 2008) was used to indicate ED pathology and items assessing specific ED behaviours (i.e., objective binge eating, self-induced vomiting, laxatives, and excessive exercise) were also used. This questionnaire also generates a number of subscales (Restraint, Eating Concern, Shape Concern, Remission was defined as a BMI ≥18.5, EDE-Q Global score <2.77 (one SD above a mean from a community sample of young women; see Fairburn, 2008) , and absence of binge eating or dysfunctional weight control behaviours (i.e., self-induced vomiting, laxative use, excessive exercise), which is in line with similar studies (e.g., Byrne et al., 2011; Turner et al., 2015) . Partial remission was defined as meeting two of these criteria (e.g., Byrne et al., 2011) .
Treatment
The treatment was a version of CBT-ED based around a leading evidence-based manual (Fairburn, 2008) and resembled that which has been recently recommended by the UK's National Institute for Health and Care Excellence (NICE, 2017) . Most elements of Fairburn's (2008) treatment, known as Enhanced CBT (or CBT-E), were followed, including regular collaborative weighing, psychoeducation (including a focus on helping patients decide to change), encouragement of full weight restoration, jointly creating a personalised formulation, regular self-monitoring, addressing core ED features, and sessions becoming less frequent towards the end of treatment. However, the service did not feel able to provide twice-weekly sessions at the outset of treatment but was otherwise consistent in delivering CBT-ED in line with guidance for the psychological treatment of underweight patients (see Fairburn, 2008) 1 . Involvement of significant others (e.g., parent, partner) was considered when it was felt that doing so would facilitate progress (Fairburn, 2008) .
Adherence was not closely monitored, although all clinicians were encouraged to deliver treatment per the manual and were supported by both individual and group supervision. Group supervision took place for one hour per fortnight and focused on key elements of the treatment manual (which was consulted at each session), helping ensure that treatment procedures were delivered consistently. Individual supervision was provided by one of three senior clinical psychologists, in line with practice recommendations for case management (typically around one hour per month). In total, 10 clinicians delivered treatment and all had attended training courses in CBT-E run by the manual's author.
In line with guidance for CBT-ED (Fairburn, 2008; NICE, 2017) , up to 40 sessions were planned. However, this was shortened in the event of rapid change and also if patients no longer wished to continue with treatment or could not routinely commit to making changes (e.g., weight restoration). Although some patients saw another member of the team (e.g., dietitian) for a review, none had additional psychological therapy. Those who required more intensive treatment (e.g., inpatient admission) following commencement of CBT-ED are included but classed as non-completers.
As in previous work, 'non-completion' was defined as "the patient ending treatment before the agreed termination point (defined by patient and clinician)" (Waller et al., 2014, p. 14) ; all other patients were deemed to have completed a course of treatment (see Figure 1 ). The majority of individuals completed treatment earlier than the planned 40 sessions; typically, patients had completed the relevant steps of treatment and experienced sufficient improvement in symptoms. Six individuals (9.5%) received more than 40 sessions, agreed in supervision, all of whom were treatment completers.
Statistical analyses
To obtain outcomes based on intent-to-treat (ITT) analysis, multiple imputation (MI) with chained equations was conducted for missing data on BMI, Global EDE-Q, SWC, CIA Total, and CORE-OM Total. Questionnaire responses were imputed at scale level given high internal consistency and construction from many items (Graham, 2009 ). Square-root transformation reduced the degree of non-normality, so transformed variables formed the basis for analysis (back-transformed to aid interpretation of results). Transformation did not correct non-normality in distribution of ED behaviours (e.g., binge eating), so MI was conducted on untransformed data given the preference for MI to other missing data methods (Graham, 2009 ).
The imputation model contained pre-treatment age and BMI as predictors and was based on linear regression for continuous variables. Twenty datasets for each outcome variable were generated. A similar procedure was carried out for ED behaviours, with the exception that imputations were estimated from age, BMI, and separate ED behaviours. Cohen's d is reported as a measure of effect size, obtained from paired samples t-tests for pre-post analysis.
In order to identify predictors of treatment completion, baseline variables were compared with independent samples t-tests, followed by logistic regression analysis (forward entry) with significant variables. The model was run with backward entry, but this did not affect the results.
To investigate the effect of treatment duration, partial correlations (controlling for EDE-Q and BMI at pre-treatment) were used to assess the relationship between number of sessions and BMI change (post-treatment BMI minus pre-treatment BMI) and EDE-Q at post-treatment (transformed data) (e.g., see Bell et al., 2017) .
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Results
Intent-to-treat analysis
Looking at the sample as a whole, there was a significant main effect of treatment on all variables (see Table 2 ). At the end of treatment, 9 individuals (14.3%) met criteria for full remission with a further 22 (34.9%) partial remission; 22 of these (71.0%) were treatment completers. Specific numbers regarding each remission criterion are provided in Table 2. Looking at diagnostic differences, Table 3 presents further information for AN and Atypical AN groups. No significant differences were found between the two groups.
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Treatment completion Twenty-nine individuals (46.0%) did not complete CBT-ED. On average, patients received 23.1 sessions of CBT-ED (range = 3 to 61) over 30.4 weeks (2 to 75).
Completers attended more sessions that non-completers (30.6 vs. 14.4, t(61) = 6.591, p < .001).
Treatment duration
Of note, 76% of those deemed to have completed CBT-ED did not require 40 sessions. Partial correlations (controlling for pre-treatment EDE-Q Global and BMI) were significant between number of treatment sessions and BMI change (r = .474, p = .003) but not EDE-Q Global at post-treatment (r = -.110, p = .522).
Outcomes of treatment completers
For those who completed a course of CBT-ED, there was a considerable response on a number of symptom measures, with large effect sizes (see Table 2 ). Mean BMI gain was 2.11kg/m 2 (SE = 0.27) and around two thirds (23/34; 67.6%) achieved a BMI ≥ 18.5. This change was significantly greater than the +0.50kg/m 2 (SE = 0.21) for non-completers (t(4044) = 4.627, p < .001). There was also significant improvement on a measure of psychological distress, and positive changes in ED behaviours. Seven individuals (20.6%) met criteria for full remission with a further 15 (44.1%) partial remission.
Effects on psychosocial impairment
Mean CIA scores had decreased significantly at end-of-treatment, with a large effect size. The mean score for completers at end-of-treatment was just below the cut-off for case status of 16 (Bohn et al., 2008) , and 20 (58.8%), scored below this. For the intent-to-treat sample, the mean was slightly higher and 37 (58.7%) scored below the cut-off.
Predictors of treatment completion
Comparison at baseline (start of treatment) revealed no differences between those who completed treatment and those who did not on BMI, SWC, EDE-Q Global, CORE Total, or CIA Total scores. Presence and frequency (two separate variables) of binge eating and purging did differ, with completers more likely to experience binge eating and purging (χ 2 (1) = 6.833, p = .009) and more episodes of binge eating and purging (23.7 vs. 4.93, t(52) = 2.927, p = .006). This variable remained significant in regression analyses whether considered as a binary (present / not) or continuous variable. Median-centring (see Kraemer and Blasey, 2004) produced identical results.
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Discussion
Underweight EDs represent some of the most difficult psychiatric illnesses to treat, although emerging evidence suggests that many patients are able to make significant gains in outpatient treatment (e.g., Fairburn et al., 2013) . Application to 'real-world' samples is formative, in part as existing case series have largely included individuals with AN only as part of larger analyses. However, this study complements well-conducted trials (e.g., Byrne et al., 2017; Fairburn et al., 2013) in reporting outcomes for adults with low-weight EDs following outpatient psychological treatment in a 'real world' setting.
The proportion of individuals who completed treatment in the current study (54%) is comparable to other 'real-world' studies (e.g., Signorini et al., 2017: 50%; Turner et al., 2015: 55%) and is slightly smaller than RCTs for underweight patients (e.g., Byrne et al., 2017: 66.7%; Fairburn et al., 2013: 64%) . As this sample wholly comprised individuals who were underweight, results suggest that completion rates for CBT-ED may not differ greatly across diagnoses, although larger studies will be needed to test this assumption. Of note, treatment completers received an average of around 31 sessions of CBT-ED, far less than typically recommended (e.g., Fairburn, 2008) . A complete explanation for this is unclear, given that adherence was not assessed, although it has been suggested that it might be possible to develop briefer versions of CBT-ED, even for those who are underweight, or for certain patients to move through the stages of treatment more rapidly than others (Waller et al., 2018) . For example, Byrne et al. (2017) amended length of treatment for AN to reflect the magnitude of weight restoration required, although no such modification was explicitly applied in the current study. Partial support for this endorsement comes from the fact that duration of treatment was related only to change in BMI, and not ED pathology, suggesting that those who remained in treatment longer restored more weight (cf. Bell et al., 2017; Rose and Waller, 2017) .
However, as outcomes were not recorded other than at pre-and post-treatment, more detailed analysis (e.g., of session-by-session change) would be beneficial to determine the optimal number of sessions required for significant change within CBT-ED.
Duration of illness in the current sample was longer than that of both Fairburn and colleagues (2013) and Byrne et al. (2017) , although other pre-treatment characteristics (e.g., gender ratio, mean BMI, degree of psychosocial impairment) were comparable. Given such similarities, existing data repeatedly points to the finding that attrition in 'real world' samples exceeds that in research settings, and is related to poorer outcome overall (e.g., Byrne et al., 2011) .
In terms of weight restorationa key goal for remission from underweight EDs -CBT-ED completers restored just over two BMI points from start to end of treatment.
In terms of remission rates, a BMI of at least 18.5kg/m 2 was achieved by over 60% of treatment completers in Fairburn et al. (2013) and over 50% of the total sample in Byrne et al. (2017) . Minimal ED pathology was achieved by 80% of those who completed treatment in Fairburn et al. In the current study, over two-thirds of completers achieved weight restoration (just under half of the ITT sample) and nearly three-quarters reported minimal ED pathology. Overall, results are encouraging given the low body weight (BMI range at start of treatment = 14.8 to 18.5) and lack of strict treatment monitoring, although more needs to be done to improve outcome for all patients given the smaller treatment effects in ITT analyses. Close adherence to evidence-based CBT-ED is a possible explanation for the positive results (Linardon et al., 2017) , although such interpretations should be cautious as no measure of adherence was included.
Other secondary outcomes were also promising, with levels of psychological distress significantly improved following treatment, in addition to reported impairment as a result of ED pathology (see also Byrne et al., 2017) . Therefore, findings support existing data that those who complete treatment report better outcomes than those who do not (e.g., see Fairburn et al., 2015) . However, given that positive results were also seen in the ITT condition (with around half achieving at least partial remission), problems around impaired access to psychological treatments (see Kazdin, Fitzsimmons-Craft, and Wilfley, 2017) and treatment completion also demand resolution.
Only one variable emerged as a significant predictor of outcomepresence of binge eating and purging was positively associated with treatment completion. However, this was highly unexpected given results of both non-randomised studies (e.g., Fairburn et al., 2013) and reviews (e.g., Vall and Wade, 2015) which suggest that higher levels of these behaviours are associated with worse outcome. Although this finding could be due to limitations of the study, such as a small number of noncompleters who engaged in binge eating and purging at the start of treatment (n = 4) and lack of randomisation, other explanations are possible. It could be, for example, that individuals were motivated to address this behaviour as part of CBT-ED (e.g., Vitousek, Watson, and Wilson, 1998) and therefore remained in treatment. It is also possible that the early focus on reducing binge eating and purging was associated with positive outcomes (e.g., see Brown, Mountford, and Waller, 2013) . Other studies (e.g., Turner et al., 2015) have, however, failed to find that the presence of binge eating and purging predicts outcome and therefore more study is warranted, perhaps considering the timing of any change in these symptoms.
Limitations of the current study include the small number of male cases and use of self-report data in assessing both symptomatology and impairment. Although the sample size was favourable compared to other studies of AN, this was too small to conduct detailed statistical analyses, such as moderator and mediator effects and certain subgroup analyses (e.g., presence of binge eating and purging). Although we considered diagnostic differences, it was not possible to look at outcomes of different groups subtyped by behavioural symptoms. Use of ICD-10 criteria (WHO, 2016) , which do not include presence of purging as an essential criterion for AN diagnosis, also limited this possibility. One further weakness of the study is also perhaps its major strength. The CBT-ED conducted, whilst closely aligned to a manual (Fairburn, 2008), was not uniform; a number of therapists delivered the treatment and the number of sessions received by completers varied from 17 to 61.
However, this also speaks to existing evidence that CBT-ED can be delivered effectively in 'real world' settings when core strategies are followed (Rose and Waller, 2017; Turner et al., 2015; Waller et al., 2018) .
Overall the results presented here suggest that individuals with AN and Atypical AN who are underweight can be treated effectively with CBT-ED in a 'real world' setting.
Outcomes are similar to RCTs and, taken together, suggest that evidence-based treatments can be readily applied with individuals with EDs in 'real world' settings.
As Turner et al. (2015) conclude, the focus should now be on enhancing retention in evidence-based treatments, given that those who adhere to treatment (i.e., completers) generally report good clinical outcomes. (ITT) ‡ N = 33 (Completers) and 62 (ITT) as one individual did not complete this measure at start-of-treatment 
